These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23331093)

  • 1. Five-year history of pruritic plaques.
    Chapman JC; Murina A; Boh E
    Int J Dermatol; 2014 Jan; 53(1):e33-5. PubMed ID: 23331093
    [No Abstract]   [Full Text] [Related]  

  • 2. Superimposed linear psoriasis: low effectiveness of biologic therapy.
    Colombo L; Marconi M; Mapelli ET; Crespi E; Gualandri L; Menni S; Cerri A
    G Ital Dermatol Venereol; 2011 Aug; 146(4):311-3. PubMed ID: 21785401
    [No Abstract]   [Full Text] [Related]  

  • 3. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept.
    Vine K; Votava HJ; Smith BL
    Cutis; 2012 Sep; 90(3):132-6. PubMed ID: 23094312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory linear verrucous epidermal nevus responsive to 308-nm excimer laser treatment.
    Grgurich E; Gupta N; Owen R; Purcell SM
    Cutis; 2018 Aug; 102(2):111-114. PubMed ID: 30235359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
    Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
    Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis.
    Stewart L; Howat A; Coulson I
    Arch Dermatol; 2010 Oct; 146(10):1193-4. PubMed ID: 20956674
    [No Abstract]   [Full Text] [Related]  

  • 8. Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept.
    Cusano F; Iannazzone SS; Riccio G; Piccirillo F
    Eur J Dermatol; 2010; 20(4):520. PubMed ID: 20403800
    [No Abstract]   [Full Text] [Related]  

  • 9. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
    Gottlieb A; Feng J; Harrison DJ; Globe D
    J Am Acad Dermatol; 2010 Oct; 63(4):580-6. PubMed ID: 20599294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Episode of pustular psoriasis after a tuberculin test in a patient with plaque psoriasis on treatment with etanercept].
    Guinovart RM; Ferrándiz C; Bielsa I; Carrascosa JM
    Actas Dermosifiliogr; 2011 Dec; 102(10):828-30. PubMed ID: 21798486
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
    Girolomoni G; Abeni D
    Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patient education. Information letter on treatment of psoriasis with etanercept (Enbrel)].
    Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
    Ann Dermatol Venereol; 2011 Dec; 138(12):871-3. PubMed ID: 22137635
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of etanercept in treating pruritus and preventing new lesions in Grover disease.
    Norman R; Chau V
    J Am Acad Dermatol; 2011 Apr; 64(4):796-8. PubMed ID: 21414507
    [No Abstract]   [Full Text] [Related]  

  • 15. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
    Yamauchi PS; Lowe NJ
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etanercept].
    Descamps V
    Ann Dermatol Venereol; 2011 Dec; 138(12):845-7. PubMed ID: 22137625
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
    Yamauchi PS; Lowe NJ; Gindi V
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
    [No Abstract]   [Full Text] [Related]  

  • 18. An inflammatory verrucous epidermal nevus concomitant with psoriasis: treatment with adalimumab.
    Özdemir M; Balevi A; Esen H
    Dermatol Online J; 2012 Oct; 18(10):11. PubMed ID: 23122018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
    Desai N; Raste Y; Cooke NT; Harland CC
    Br J Dermatol; 2008 May; 158(5):1137-8. PubMed ID: 18279462
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-TNF-alpha therapy in childhood pustular psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
    Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.